Adverum Biotechnologies Inc

24 أكتوبر 2025، 01:04 م UTC

Eli Lilly Agrees to Acquire Adverum Biotechnologies

9 ديسمبر 2025، 01:32 م UTC

Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY

9 ديسمبر 2025، 01:32 م UTC

Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs

9 ديسمبر 2025، 01:29 م UTC

Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition

24 أكتوبر 2025، 12:34 م UTC

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 أكتوبر 2025، 12:34 م UTC

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 أكتوبر 2025، 12:33 م UTC

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 أكتوبر 2025، 12:30 م UTC

Lilly To Acquire Adverum Biotechnologies >LLY ADVM